DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aster DM Quality Care Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 55 min ago·8 Oct 2026, 10:03 am

Aster DM Quality Care

Aster DM Quality Care Limited has submitted a certificate to the stock exchange, confirming that it has complied with the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending September 30, 2026. This document is a standard regulatory filing required for listed companies to maintain transparency regarding their compliance with securities market rules.

For investors, this update is largely a procedural confirmation. It indicates that the company has fulfilled its statutory obligations related to its depository activities, such as maintaining accurate records of dematerialized shares. It does not typically signal any major operational changes or financial news, serving instead as a routine administrative update.

Investors should view this as a standard compliance filing rather than a market-moving event. The focus should remain on the company's core healthcare operations and future growth plans. There are no immediate specific triggers for price movement based on this announcement alone.